Le Versoud, France

Thomas Lavergne

USPTO Granted Patents = 3 

Average Co-Inventor Count = 5.0

ph-index = 2

Forward Citations = 11(Granted Patents)


Location History:

  • Le Versoud, FR (2020)
  • La Versoud, FR (2023)

Company Filing History:


Years Active: 2020-2025

Loading Chart...
3 patents (USPTO):

Title: Thomas Lavergne: Innovator in Nucleic Acid Research

Introduction

Thomas Lavergne is a notable inventor based in Le Versoud, France. He has made significant contributions to the field of nucleic acid research, holding three patents that showcase his innovative approaches. His work primarily focuses on the incorporation of unnatural nucleotides, which has implications for various applications in biotechnology and molecular biology.

Latest Patents

One of Lavergne's latest patents is a method for the site-specific enzymatic labeling of nucleic acids in vitro by incorporating unnatural nucleotides. This patent describes analogs of unnatural nucleotides that feature predominantly hydrophobic nucleobase analogs. These analogs are capable of forming unnatural base pairs during DNA polymerase-mediated replication or RNA polymerase-mediated transcription. This method allows for the introduction of unnatural nucleobases in a site-specific manner into oligonucleotides, which can facilitate site-specific cleavage or provide a reactive linker for functionalization with cargo-bearing reagents.

Career Highlights

Throughout his career, Thomas Lavergne has worked with prestigious organizations, including The Scripps Research Institute and the U.S. Government's National Institutes of Health Division of Extramural Inventions and Technology Resources. His work in these institutions has allowed him to advance his research and contribute to the scientific community.

Collaborations

Lavergne has collaborated with notable scientists in his field, including Floyd E. Romesberg and Denis A. Malyshev. These collaborations have further enriched his research and have led to significant advancements in the understanding of nucleic acids.

Conclusion

Thomas Lavergne's innovative work in the field of nucleic acids, particularly through his patents on unnatural nucleotides, highlights his contributions to biotechnology. His collaborations and career achievements reflect his dedication to advancing scientific knowledge and technology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…